These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37248188)

  • 1. [A case of malignant peritoneal mesothelioma].
    Zhao F; Zhang YL; Liu X; Chen TH; Li J
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Apr; 41(4):307-309. PubMed ID: 37248188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced epithelioid pleural mesothelioma, long lasting disease stabilization and long term survival with cisplatin-pemetrexed chemotherapy re-challenge: a case report.
    Cirino C; Veltri E
    Clin Ter; 2016; 167(1):10-2. PubMed ID: 26980632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant peritoneal mesothelioma.
    Chun CP; Song LX; Zhang HP; Guo DD; Xu GX; Li Y; Xin X; Cao J; Li F
    Am J Med Sci; 2023 Jan; 365(1):99-103. PubMed ID: 35940275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesothelioma.
    Nagata Y; Sawada R; Takashima A; Shoji H; Honma Y; Iwasa S; Amano K; Kato K; Hamaguchi T; Shimada Y; Saruta M; Boku N
    Jpn J Clin Oncol; 2019 Dec; 49(11):1004-1008. PubMed ID: 31287877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant Peritoneal Mesothelioma Diagnosed as an Inguinal Mass : A Case Report].
    Araki Y; Ikeda M; Iribe Y; Asaoka M; Uemura K; Sano F; Ikeda I
    Hinyokika Kiyo; 2021 Oct; 67(10):475-477. PubMed ID: 34742174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the Efficacy of Pemetrexed Maintenance Therapy in Patients with 
Malignant Pleural Mesothelioma].
    Zeng X; Jiang Z; Duan J
    Zhongguo Fei Ai Za Zhi; 2022 Jan; 25(1):7-13. PubMed ID: 35078279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma.
    Karatkevich D; Deng H; Gao Y; Flint E; Peng RW; Schmid RA; Dorn P; Marti TM
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model.
    Sonvico F; Barbieri S; Colombo P; Barocelli E; Mucchino C; Cantoni AM; Petronini PG; Rusca M; Carbognani P; Ampollini L
    Eur J Pharm Sci; 2018 Oct; 123():89-97. PubMed ID: 30030099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin.
    Kim JS; Lim SY; Hwang J; Kang EJ; Choi YJ
    J Korean Med Sci; 2017 Nov; 32(11):1879-1884. PubMed ID: 28960045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Malignant Peritoneal Mesothelioma.
    Levý M; Boublíková L; Büchler T; Šimša J
    Klin Onkol; 2019; 32(5):333-337. PubMed ID: 31610664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
    Tsao AS; Miao J; Wistuba II; Vogelzang NJ; Heymach JV; Fossella FV; Lu C; Velasco MR; Box-Noriega B; Hueftle JG; Gadgeel S; Redman MW; Gandara DR; Kelly K
    J Clin Oncol; 2019 Oct; 37(28):2537-2547. PubMed ID: 31386610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffuse Malignant Peritoneal Mesothelioma with Secondary Liver Invasion Diagnosed Using Laparoscopy - A Case Report].
    Yasuda H; Okumura S; Toyoda S; Yamamoto K; Mizumura N; Itou A; Ogawa M; Kawasaki M; Kameyama M
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):449-453. PubMed ID: 29650903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal mesothelioma: the site of origin matters.
    Kindler HL
    Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma.
    Horio D; Minami T; Kitai H; Ishigaki H; Higashiguchi Y; Kondo N; Hirota S; Kitajima K; Nakajima Y; Koda Y; Fujimoto E; Negi Y; Niki M; Kanemura S; Shibata E; Mikami K; Takahashi R; Yokoi T; Kuribayashi K; Kijima T
    Cancer Sci; 2020 Aug; 111(8):2895-2906. PubMed ID: 32530527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting.
    Waterhouse DM; Nwokeji ED; Boyd M; Penrod JR; Espirito JL; Robert NJ; Daumont MJ
    Future Oncol; 2021 Jul; 17(19):2439-2448. PubMed ID: 33769073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneal mesothelioma: an inusual clinical presentation in a patient without exposure to asbestos].
    Ponce Lorenzo J; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Montalar Salcedo J
    An Med Interna; 2007 Feb; 24(2):81-3. PubMed ID: 17590095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Dilemma: Primary Peritoneal Mesothelioma With Para-Occupational Asbestos Exposure.
    Qin KR; Dua D
    J Glob Oncol; 2017 Dec; 3(6):828-832. PubMed ID: 29244982
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-tumor immunotherapy in malignant pleural mesothelioma].
    Scherpereel A; Willemin MC; Wasielewski E; Dhalluin X
    Rev Mal Respir; 2018 Apr; 35(4):465-476. PubMed ID: 29415822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pembrolizumab plus chemotherapy for pleural mesothelioma.
    Lee YCG
    Lancet; 2023 Dec; 402(10419):2266-2267. PubMed ID: 37931626
    [No Abstract]   [Full Text] [Related]  

  • 20. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
    Zalcman G; Mazieres J; Margery J; Greillier L; Audigier-Valette C; Moro-Sibilot D; Molinier O; Corre R; Monnet I; Gounant V; Rivière F; Janicot H; Gervais R; Locher C; Milleron B; Tran Q; Lebitasy MP; Morin F; Creveuil C; Parienti JJ; Scherpereel A;
    Lancet; 2016 Apr; 387(10026):1405-1414. PubMed ID: 26719230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.